ADBiotech Co., Ltd. (KOSDAQ:179530)
South Korea
· Delayed Price · Currency is KRW 2,955.00
+80.00 (2.78%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Biotechnology | 10.46B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Biotechnology Growth | 21.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Online Platforms | 673.29M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Online Platforms Growth | -64.09% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consolidation Adjustment | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Medicines, Supplementary Food, Health Functional Foods Product | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Medicines, Supplementary Food, Health Functional Foods Product Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Medicines, Supplementary Food, Health Functional Foods Merchandise | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Animal Medicines, Supplementary Food, Health Functional Foods Merchandise Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commission | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Commission Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| South Korea | 6.80B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| South Korea Growth | -15.72% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia | 4.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia Growth | 80.62% |
Log In |
Log In |
Log In |
Log In | Upgrade
|